Clinical trial diversity is a balancing act of time, quality, and money

[cafead]

via While the topic of clinical trial diversity has been in circulation for some time, it has recently gained traction with the US Food and Drug Administration (FDA) releasing a guidance shepherding sponsors on the implementation of diversity plans.

article source